352770 — Celestra Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- KR₩14bn
- KR₩44bn
- KR₩9bn
Annual cashflow statement for Celestra, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -13,147 | 15,853 | -10,234 | -42,399 | -47,055 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 3,261 | 9,323 | 416 | 28,881 | 32,578 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 60.8 | -25,452 | -5,743 | -1,331 | 34.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7,965 | 2,367 | -11,543 | -10,598 | -11,012 |
Capital Expenditures | -4,481 | -10,276 | -12,940 | -1,927 | -25,794 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -3,248 | -17,732 | 9,963 | 8,661 | 5,323 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -7,728 | -28,009 | -2,977 | 6,734 | -20,471 |
Financing Cash Flow Items | -1,708 | -23.2 | — | -420 | -286 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 25,956 | 29,607 | 6,279 | 6,312 | 22,040 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 10,261 | 4,003 | -8,237 | 2,448 | -9,441 |